Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-691
Closed -$217K 733
2025
Q2
$217K Buy
+691
New +$207K 0.07% 448
2024
Q4
Sell
-3,742
Closed -$1.25M 552
2024
Q3
$1.25M Buy
3,742
+1,588
+74% +$603K 0.38% 82
2024
Q2
$887K Buy
+2,154
New +$853K 0.21% 181
2023
Q1
Sell
-2,815
Closed -$598K 575
2022
Q4
$598K Buy
+2,815
New +$562K 0.42% 81

Other funds holding MEDP

AXQ Capital's MEDP Position: Q3 2025 in Review

AXQ Capital sold out of Medpace (MEDP) in Q3 2025, closing a stake of 691 shares — an estimated $217K sold.

AXQ Capital first reported a position in MEDP in Q4 2022 and held it in 4 quarters. The position peaked at $1.25M in Q3 2024. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • AXQ Capital reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • AXQ Capital sold 691 Medpace shares in Q3 2025, an estimated $217K.
  • AXQ Capital first reported a position in Medpace in Q4 2022 and held it in 4 quarters.
  • AXQ Capital's Medpace position peaked at $1.25M in Q3 2024.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.